EMEND is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Fosaprepitant Dimeglumine.
| Product ID | 0006-3941_46054db2-5cc3-4a8d-86a3-f11f687f3d30 | 
| NDC | 0006-3941 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | EMEND | 
| Generic Name | Fosaprepitant Dimeglumine | 
| Dosage Form | Injection, Powder, Lyophilized, For Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2010-11-12 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA022023 | 
| Labeler Name | Merck Sharp & Dohme Corp. | 
| Substance Name | FOSAPREPITANT DIMEGLUMINE | 
| Active Ingredient Strength | 150 mg/5mL | 
| Pharm Classes | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2010-11-12 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA022023 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2010-11-12 | 
| Marketing Category | NDA | 
| Application Number | NDA022023 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2010-11-12 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| FOSAPREPITANT DIMEGLUMINE | 150 mg/5mL | 
| SPL SET ID: | 44f634f4-b794-4d55-8ab7-037fdef8ff0f | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0006-0461 | EMEND | aprepitant | 
| 0006-0462 | EMEND | aprepitant | 
| 0006-0464 | EMEND | aprepitant | 
| 0006-3061 | EMEND | FOSAPREPITANT DIMEGLUMINE | 
| 0006-3066 | EMEND | aprepitant | 
| 0006-3862 | EMEND | aprepitant | 
| 0006-3941 | EMEND | EMEND | 
| 42254-160 | EMEND | EMEND | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() EMEND  98452421  not registered Live/Pending  | 
        EMEND, LLC  2024-03-15  | 
![]() EMEND  90879357  not registered Live/Pending  | 
        EMEND, LLC  2021-08-12  | 
![]() EMEND  90879262  not registered Live/Pending  | 
        EMEND, LLC  2021-08-12  | 
![]() EMEND  90816895  not registered Live/Pending  | 
        EMEND, LLC  2021-07-08  | 
![]() EMEND  88511573  not registered Live/Pending  | 
        Lonza Ltd.  2019-07-12  | 
![]() EMEND  78449789  3154890 Live/Registered  | 
        Medion Corporation  2004-07-13  | 
![]() EMEND  76254977  2725335 Dead/Cancelled  | 
        Merck & Co., Inc.  2001-05-10  | 
![]() EMEND  75292656  2417822 Live/Registered  | 
        MERCK & CO., Inc.  1997-05-15  | 
![]() EMEND  74619649  2032756 Dead/Cancelled  | 
        CLINITEX MEDICAL CORPORATION  1995-01-10  |